David Kirn

David Kirn

Fortune : 15 M $ au 31/05/2026

64 ans
Health Technology
Consumer Services
Commercial Services

Profil

David H.
Kirn
was the founder of SillaJen Biotherapeutics, Inc., founded in 2006, where the title held was President & Chief Medical Officer in 2012.
Dr. Kirn is the founder of 4D Molecular Therapeutics, Inc., founded in 2013, holding the titles of President, Chief Executive Officer & Director starting in 2026.
Dr. Kirn is also the founder of Ignite Immunotherapy, Inc...
Dr. Kirn is Chief Executive Officer at ReIGNITE Therapeutics, Inc. Dr. Kirn is Director at Coagulant Therapeutics, Inc. Dr. Kirn is Professor at the University of Oxford.
Former positions include Principal at Warner-Lambert Co., Principal at Onyx Pharmaceuticals, Inc. in 2009, Member at Harvard University, Faculty Member at The University of California, San Francisco, Advisor at National Institutes of Health, Principal at IP2IPO Innovations Ltd., and Faculty Member at Specialist Diabetes Research & Treatment Centre LLC.
Education includes an undergraduate degree from the University of California, Berkeley in 1985 and a doctorate from The University of California, San Francisco in 1989.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
22/06/2026 1 542 485 ( 2,95 % ) 15 M $ 31/05/2026

Postes actifs de David Kirn

SociétésPosteDébut
4D MOLECULAR THERAPEUTICS, INC. Fondateur 12/09/2013
Corporate Officer/Principal -
Directeur/Membre du Conseil -

Anciens postes connus de David Kirn

SociétésPosteFin
Fondateur 01/01/2019
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de David Kirn

Formation de David Kirn

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

88

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Government

Commercial Services

Health Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. David Kirn
🔇